[HTML][HTML] Portal hypertensive gastropathy: a systematic review of the pathophysiology, clinical presentation, natural history and therapy
M Gjeorgjievski, MS Cappell - World journal of hepatology, 2016 - ncbi.nlm.nih.gov
AIM: To describe the pathophysiology, clinical presentation, natural history, and therapy of
portal hypertensive gastropathy (PHG) based on a systematic literature review. METHODS …
portal hypertensive gastropathy (PHG) based on a systematic literature review. METHODS …
Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship
Proton pump inhibitors (PPIs) have been available for over three decades and are among
the most commonly prescribed medications. They are effective in treating a variety of gastric …
the most commonly prescribed medications. They are effective in treating a variety of gastric …
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind …
MH Wehmeyer, T Horvatits, A Buchholz, L Krause… - Trials, 2022 - Springer
Background Proton-pump inhibitors (PPI) are liberally prescribed in patients with liver
cirrhosis. Observational studies link PPI therapy in cirrhotic patients with an increased risk …
cirrhosis. Observational studies link PPI therapy in cirrhotic patients with an increased risk …
Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review
EAG Lo, KJ Wilby, MHH Ensom - Annals of …, 2015 - journals.sagepub.com
Objective: To review the efficacy and safety of proton pump inhibitors (PPIs) in
gastroesophageal varices (GEVs). Data Sources: MEDLINE (1946 to September 2014) …
gastroesophageal varices (GEVs). Data Sources: MEDLINE (1946 to September 2014) …
Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with …
DK Li, P Yan, AB Abou‐Samra… - Alimentary …, 2018 - Wiley Online Library
Background Proton pump inhibitors are among the most commonly prescribed medications
in the United States. Their safety in cirrhosis has recently been questioned, but their overall …
in the United States. Their safety in cirrhosis has recently been questioned, but their overall …
Deleterious effect of proton pump inhibitors on the disease course of cirrhosis
Objectives Proton pump inhibitors (PPIs) are widely prescribed to patients with liver
cirrhosis. We hypothesized that long-standing PPI use is associated with spontaneous …
cirrhosis. We hypothesized that long-standing PPI use is associated with spontaneous …
Acid-suppressive therapy and risk of infections: pros and cons
L Fisher, A Fisher - Clinical drug investigation, 2017 - Springer
This narrative review summarises the benefits, risks and appropriate use of acid-
suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …
suppressing drugs (ASDs), proton pump inhibitors and histamine-2 receptor antagonists …
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and …
L China, T Tittanegro, D Crocombe, E Forrest… - …, 2023 - thelancet.com
Summary Background Proton pump inhibitors (PPIs) are commonly prescribed to prevent
and treat upper gastrointestinal ulceration and bleeding. Studies have identified increased …
and treat upper gastrointestinal ulceration and bleeding. Studies have identified increased …
The impact of proton pump inhibitor therapy on patients with liver disease
HL Cole, S Pennycook… - Alimentary pharmacology & …, 2016 - Wiley Online Library
Background Proton pump inhibitor (PPI) therapy has been reported to be an independent
mortality risk factor in patients with cirrhosis. Aim To identify the prevalence of PPI …
mortality risk factor in patients with cirrhosis. Aim To identify the prevalence of PPI …
The efficacy of proton pump inhibitor in cirrhotics with variceal bleeding: a systemic review and meta-analysis
L Lin, B Cui, Y Deng, X Jiang, W Liu, C Sun - Digestion, 2021 - karger.com
Abstract Background and Aims: Proton pump inhibitor (PPI) was widely used in cirrhotic
patients with variceal bleeding empirically rather than evidence-based practice. We aimed to …
patients with variceal bleeding empirically rather than evidence-based practice. We aimed to …